Smith, Scott A. http://orcid.org/0000-0001-5153-2726
Chruszcz, Maksymilian
Chapman, Martin D. http://orcid.org/0000-0002-0845-3632
Pomés, Anna http://orcid.org/0000-0002-8729-1829
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R01AI155668, R01AI077653, R21AI123307)
Article History
Accepted: 14 October 2022
First Online: 2 December 2022
Compliance with Ethical Standards
:
: Scott A Smith reports grants from NIAID R21AI123307, and NIAID R01AI155668, during the conduct of the study; In addition, Dr. Smith has a patent 10,908,168 with royalties paid, a pending patents 63/159,764 and 63/125,099 with royalties paid. Maksymilian Chruszcz declares no conflict of interest. Martin D. Chapman reports grants from NIH—NIAID, during the conduct of the study; and License agreement with Vanderbilt University Medical Center for commercialization of human IgE monoclonal antibodies for research and diagnostic purposes. The hIgE mAb covered by this agreement are available from InBio (ExternalRef removed). Anna Pomés reports a grant from NIH – NIAID 5R01AI077653-12 and is employed by InBio.
: This article does not contain any studies with human or animal subjects performed by any of the authors.